| Primary |
| Diabetes Mellitus |
55.2% |
| Type 2 Diabetes Mellitus |
21.5% |
| Type 1 Diabetes Mellitus |
7.4% |
| Product Used For Unknown Indication |
4.9% |
| Hypertension |
2.5% |
| Blood Pressure |
1.2% |
| Alopecia |
0.6% |
| Antiplatelet Therapy |
0.6% |
| Back Injury |
0.6% |
| Bladder Disorder |
0.6% |
| Blood Cholesterol |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Blood Glucose Increased |
0.6% |
| Depression |
0.6% |
| Immune System Disorder |
0.6% |
| Impaired Gastric Emptying |
0.6% |
| Pain |
0.6% |
| Sleep Apnoea Syndrome |
0.6% |
|
| Visual Impairment |
11.3% |
| Weight Decreased |
9.7% |
| Incorrect Dose Administered |
8.1% |
| Renal Failure |
6.5% |
| Visual Acuity Reduced |
6.5% |
| Weight Increased |
6.5% |
| Blindness |
4.8% |
| Cerebrovascular Accident |
4.8% |
| Myocardial Infarction |
4.8% |
| Urticaria |
4.8% |
| Drug Dose Omission |
3.2% |
| Hospitalisation |
3.2% |
| Hypoglycaemia |
3.2% |
| Pneumonia |
3.2% |
| Tremor |
3.2% |
| Underdose |
3.2% |
| Urinary Tract Infection |
3.2% |
| Vascular Graft |
3.2% |
| Vision Blurred |
3.2% |
| Vitreous Haemorrhage |
3.2% |
|
| Secondary |
| Diabetes Mellitus |
48.2% |
| Type 2 Diabetes Mellitus |
27.9% |
| Type 1 Diabetes Mellitus |
8.6% |
| Immune System Disorder |
3.0% |
| Bladder Disorder |
2.0% |
| Blood Pressure |
2.0% |
| Hypertension |
2.0% |
| Osteoporosis |
1.0% |
| Pain |
1.0% |
| Alopecia |
0.5% |
| Blood Pressure Increased |
0.5% |
| Depression |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Nasal Septum Deviation |
0.5% |
| Osteoarthritis |
0.5% |
| Product Used For Unknown Indication |
0.5% |
| Stent Placement |
0.5% |
|
| Incorrect Dose Administered |
9.2% |
| Visual Impairment |
9.2% |
| Wound |
9.2% |
| Vision Blurred |
7.9% |
| Speech Disorder |
6.6% |
| Weight Decreased |
6.6% |
| Urinary Tract Infection |
5.3% |
| Visual Acuity Reduced |
5.3% |
| Weight Increased |
5.3% |
| Atrial Fibrillation |
3.9% |
| Nervousness |
3.9% |
| Pericardial Effusion |
3.9% |
| Pneumonia |
3.9% |
| Vascular Graft |
3.9% |
| Cholelithiasis |
2.6% |
| Drug Ineffective |
2.6% |
| Hypoglycaemia |
2.6% |
| Malaise |
2.6% |
| Pain |
2.6% |
| Renal Failure Chronic |
2.6% |
|
| Concomitant |
|
| Death |
50.0% |
| Tonsil Cancer |
50.0% |
|
| Interacting |
| Type 1 Diabetes Mellitus |
100.0% |
|
| Unresponsive To Stimuli |
100.0% |
|
